Development of Theoretical Approaches to Pharmaceutical Care Improvement Considering the Modern Requirements of Health-Care System in Ukraine

Abstract

Objective: The objective of this research was to formulate the theoretical approaches to the improvement of pharmaceutical care considering the modern requirements of the public health system in Ukraine.Methods: The analysis of pharmaceutical care has been performed using “policy triangle” model. The pharmaceutical care policy model has been developed by applying the process approach.Results: The model of pharmaceutical care as a structural element of the national health policy has been developed. This model describes mechanisms by which the content, context, and process of the pharmaceutical care policy are influenced by the content, context, and process of the national health policy. Furthermore, we have defined the actors of the pharmaceutical care policy which are groups and organizations of various levels involved in the formation and development of the pharmaceutical care policy. Then, the structure of the pharmaceutical care policy has been elaborated. This policy is integrated into the national health-care system and is adapted to the good pharmacy practice requirements. The center of the policy is a process of pharmaceutical care delivering. The inputs, outcomes, management, and resources that are required for the pharmaceutical care process and provided by the actors have been identified. The data streams within this structure demonstrate implementation of the key elements of the pharmaceutical care process: Patient involvement, patient counseling and education, interprofessional collaboration, documentation of interaction, and follow-up. Furthermore, the mechanism of continual education and increasing of the professional level has been described in this structure.Conclusion: Proposed framework provides a comprehensive view of pharmaceutical care as a structural element of the national health policy considering new trends of the Ukrainian health system. The proposed model of the pharmaceutical care policy allows policy-makers to address all critical-to-quality aspects and stakeholders’ needs.

Health policy triangle framework: Narrative review of the recent literature

“…It is assumed that the authors accidentally miscited the policy triangle framework in their study. k Zupanets et al [ 86 ], 2018 – It is unclear which genre of study design best describes this article. For the purposes of this review, its study design was dubbed as a ‘ theoretical analysis ’.…”

“… k Zupanets et al [ 86 ], 2018 – It is unclear which genre of study design best describes this article. For the purposes of this review, its study design was dubbed as a ‘ theoretical analysis ’.…”

“…Abolhassani et al reviewed medication safety policy that saw the establishment of the drug naming committee to restrict look-alike medication names [ 36 ]. Alostad et al investigated herbal medicine registration systems policy [ 38 ] while Zupanets et al sought to formulate theoretical approaches to the improvement of pharmaceutical care and health system integration [ 86 ].…”

Analysis of Costs Associated with the Use of Personalized Automated Dosing Systems versus Manual Preparation in a Residential Center for the Elderly in Extremadura

“…In the SARS-CoV-2 pandemic situation, the need to improve the continuity of care and ensure access to medicines in a safe and efficient manner became evident [1][2][3][4]. The pandemic has greatly affected the care of chronic pathologies [5,6]. In the case of polymedicated, non-institutionalised patients with multiple pathologies, there is also a decrease in the supervision of medication by relatives or direct caregivers, as visits have been reduced due to periods of restricted mobility [5,7].…”

“…The pandemic has greatly affected the care of chronic pathologies [5,6]. In the case of polymedicated, non-institutionalised patients with multiple pathologies, there is also a decrease in the supervision of medication by relatives or direct caregivers, as visits have been reduced due to periods of restricted mobility [5,7].…”